Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Cincinnati Children's Hospital Medical Center · Texas Scottish Rite Hospital for Children · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
784
total citations
- FWCI
- 39.77
- Percentile
- 100%
- References
- 34
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Tuberous sclerosis
- Subependymal giant cell astrocytoma
- Subependymal zone
- Everolimus
- Medicine
- Placebo
- Clinical endpoint
- Hydrocephalus
No related works found for this paper.